Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

676 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Allopurinol as a cardiovascular drug.
Kelkar A, Kuo A, Frishman WH. Kelkar A, et al. Among authors: frishman wh. Cardiol Rev. 2011 Nov-Dec;19(6):265-71. doi: 10.1097/CRD.0b013e318229a908. Cardiol Rev. 2011. PMID: 21983313 Review.
Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure.
Sokol SI, Cheng A, Frishman WH, Kaza CS. Sokol SI, et al. Among authors: frishman wh. J Clin Pharmacol. 2000 Jan;40(1):11-30. doi: 10.1177/00912700022008649. J Clin Pharmacol. 2000. PMID: 10631618 Review.
Cardiovascular drug therapy in the elderly.
Aronow WS, Frishman WH, Cheng-Lai A. Aronow WS, et al. Among authors: frishman wh. Heart Dis. 2000 Mar-Apr;2(2):151-67. Heart Dis. 2000. PMID: 11728253 Review.
Recombinant growth hormone: a new cardiovascular drug therapy.
Gomberg-Maitland M, Frishman WH. Gomberg-Maitland M, et al. Among authors: frishman wh. Am Heart J. 1996 Dec;132(6):1244-62. doi: 10.1016/s0002-8703(96)90469-x. Am Heart J. 1996. PMID: 8969577 Review.
Cardiovascular disease in the elderly. Clinical assessment.
Frishman WH, DeMaria AN, Ewy GA. Frishman WH, et al. J Am Coll Cardiol. 1987 Aug;10(2 Suppl A):48A-51A. doi: 10.1016/s0735-1097(87)80448-5. J Am Coll Cardiol. 1987. PMID: 3298369 Review.
Recent advances in cardiovascular pharmacology.
Frishman WH. Frishman WH. Curr Probl Cardiol. 2000 Apr;25(4):227-95. doi: 10.1016/s0146-2806(00)70011-9. Curr Probl Cardiol. 2000. PMID: 10751734 Review. No abstract available.
A new potential approach to inotropic therapy in the treatment of heart failure: urocortin.
Garg V, Frishman WH. Garg V, et al. Among authors: frishman wh. Cardiol Rev. 2013 May-Jun;21(3):160-5. doi: 10.1097/CRD.0b013e31827ed0c9. Cardiol Rev. 2013. PMID: 23269034 Review.
Cardiovascular drug therapy in the elderly: benefits and challenges.
Fleg JL, Aronow WS, Frishman WH. Fleg JL, et al. Among authors: frishman wh. Nat Rev Cardiol. 2011 Jan;8(1):13-28. doi: 10.1038/nrcardio.2010.162. Epub 2010 Oct 26. Nat Rev Cardiol. 2011. PMID: 20978470 Review.
Vernakalant: a new drug to treat patients with acute onset atrial fibrillation.
Tian D, Frishman WH. Tian D, et al. Among authors: frishman wh. Cardiol Rev. 2011 Jan-Feb;19(1):41-4. doi: 10.1097/CRD.0b013e3181f4a6a2. Cardiol Rev. 2011. PMID: 21135602
Urotensin II: a new pharmacologic target in the treatment of cardiovascular disease.
Desai N, Sajjad J, Frishman WH. Desai N, et al. Among authors: frishman wh. Cardiol Rev. 2008 May-Jun;16(3):142-53. doi: 10.1097/CRD.0b013e31815c8048. Cardiol Rev. 2008. PMID: 18414185 Review.
676 results
Jump to page
Feedback